Steffen Schmitz-Valckenberg, MD, discusses how optical coherence tomography-based models may enable rapid, noninvasive assessment of functional loss in GA at Angiogenesis 2026.

This buzzy natural filler promises subtle, low-risk results. We dig into what’s really in the syringe, who’s injecting it, and the risks you need to know.

Gardner: You’ve spent decades supporting medical device programs. How does medical industry tooling differ from tooling in ...